Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("ABVD")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 67

  • Page / 3
Export

Selection :

  • and

TREATMENT OF MOPP-RESISTANT HODGKIN'S DISEASE WITH ADRIAMYCIN, BLEOMYCIN, VINBLASTINE AND DACARBAZINE (ABVD)PAPA G; MANDELLI F; DE LUCA AM et al.1982; EUR. J. CANCER CLIN. ONCOL.; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 9; PP. 803-806; BIBL. 11 REF.Article

DTIC - BESTANDTEIL EINER THERAPIEKOMBINATION (ABVD) BEI MORBUS HODGKIN = DTIC - PARTIE INTEGRANTE DU TRAITEMENT COMBINE (ABVD) DE LA MALADIE DE HODGKINLUTZ D; WALDNER R; HOECKER P et al.1978; WIEN. KLIN. WSCHR.; AUT; DA. 1978; VOL. 90; NO 24; PP. 876-877; ABS. ENG; BIBL. 15 REF.Article

A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI) without consolidation radiotherapy in patients with advanced Hodgkin lymphomaRUSSO, Filippo; CORAZZELLI, Gaetano; DONNARUMMA, Daniela et al.British journal of haematology. 2014, Vol 166, Num 1, pp 118-129, issn 0007-1048, 12 p.Article

Lymphome de hodgkin (LH) : avancées et perspectives récentes : Hématologie maligne = Hodgkin's lymphoma (HL) : recent advances and prospectsITALIANO, A; THYSS, A.Oncologie (Paris). 2006, Vol 8, Num 4, pp 337-343, issn 1292-3818, 7 p.Article

Haematological toxicity compromises MOPP/ABVD chemotherapy on Hodgkin's diseaseGOODRICK, M. J; DANIEL, F; PRENTICE, A. G et al.Clinical oncology. 1991, Vol 3, Num 3, pp 151-154Article

Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in JapanYOTSUMOTO, Mihoko; HAGIWARA, Shotaro; UNO, Kenji et al.International journal of hematology. 2012, Vol 96, Num 2, pp 247-253, issn 0925-5710, 7 p.Article

ABVD TREATMENT OF MOPP FAILURES IN HODGKIN'S DISEASE: A RE-EXAMINATION OF GOALS OF SALVAGE THERAPY.CLAMON GH; CORDER MP.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 3; PP. 363-367; BIBL. 23 REF.Article

COMBINED CHEMOTHERAPY (MOPP OR ABVD-RADIOTHERAPY APPROACH IN ADVANCED HODGKIN'S DISEASE.BONADONNA G; ZUCALI R; DE LENA M et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 5; PP. 769-777; BIBL. 34 REF.Article

Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study GroupBEHRINGER, K; MÜLLER, H; FUCHS, M et al.British journal of cancer. 2013, Vol 108, Num 1, pp 49-57, issn 0007-0920, 9 p.Article

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD coursesGALLAMINI, Andrea; PATTI, Caterina; SORASIO, Roberto et al.British journal of haematology. 2011, Vol 152, Num 5, pp 551-560, issn 0007-1048, 10 p.Article

LA CHEMIOTERAPIA DEI LINFOMI MALIGNI. = LA CHIMIOTHERAPIE DES LYMPHOMES MALINSLUPORINI G.1976; RADIOL. MED.; ITAL.; DA. 1976; VOL. 62; NO 7-8; PP. 553-557; ABS. ANGL.; BIBL. 7 REF.Article

ABSENCE OF TREATMENT-INDUCED SECOND NEOPLASMS AFTER ABVD IN HODGKIN'S DISEASEVALAGUSSA P; SANTORO A; FOSSATI BELLANI F et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 3; PP. 488-494; BIBL. 39 REF.Article

Hodgkin lymphomaGOBBI, Paolo G; FERRERI, Andres J. M; PONZONI, Maurilio et al.Critical reviews in oncology/hematology. 2013, Vol 85, Num 2, pp 216-236, issn 1040-8428, 21 p.Article

Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphomaOFLAZOGLU, Ezogelin; KISSLER, Kim M; SIEVERS, Eric L et al.British journal of haematology. 2008, Vol 142, Num 1, pp 69-73, issn 0007-1048, 5 p.Article

Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphomaXICOY, Blanca; RIBERA, Josep-Maria; MORGADES, Mireia et al.Haematologica (Roma). 2007, Vol 92, Num 2, pp 191-198, issn 0390-6078, 8 p.Article

Survival in Hodgkin's disease patients : Report of 25 years of experience at the Milan Cancer InstituteBONADONNA, Gianni; VIVIANI, Simonetta; BONFANTE, Valeria et al.European journal of cancer (1990). 2005, Vol 41, Num 7, pp 998-1006, issn 0959-8049, 9 p.Article

A selective history of the therapy of Hodgkin's diseaseDEVITA, Vincent T.British journal of haematology. 2003, Vol 122, Num 5, pp 718-727, issn 0007-1048, 10 p.Article

Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosisLANDGREN, Ola; ALGERNON, Cecilia; AXDORPH, Ulla et al.Haematologica (Roma). 2003, Vol 88, Num 4, pp 438-444, issn 0390-6078, 7 p.Article

COMBINATION CHEMOTHERAPY OF MOPP-RESISTANT HODGKIN'S DISEASE WITH ADRIAMYCIN, BLEOMYCIN, DACARBAZINE AND VINBLASTINE (ABDV).CASE DC JR; YOUNG CW; LEE BJ III et al.1977; CANCER; U.S.A.; DA. 1977; VOL. 39; NO 4; PP. 1382-1386; BIBL. 21 REF.Article

ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma : results from an Intergruppo Italiano Linfomi randomized studyPAVONE, V; RICARDI, U; ANGELUCCI, E et al.Annals of oncology. 2008, Vol 19, Num 4, pp 763-768, issn 0923-7534, 6 p.Article

Traitement des formes localisées de la maladie de Hodgkin par 3 cures de chimiothérapie (ABVD-MP) associées à une radiothérapie focale élargie et lombo-splénique prophylactique = Treatment of localized Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) followed by wide focal and prophylactic lumbo-splenic radiotherapyDESABLENS, B; TOURANI, J. M; ANDRIEU, J. M et al.La Presse médicale (1983). 1989, Vol 18, Num 39, pp 1917-1921, issn 0755-4982Article

Evaluation of therapeutic modalities in the control of Hodgkin's diseaseMANDELLI, F; ANSELMO, A. P; CARTONI, C et al.International journal of radiation oncology, biology, physics. 1986, Vol 12, Num 9, pp 1617-1620, issn 0360-3016Conference Paper

COMBINATION CHEMOTHERAPY SALVAGE OF HEAVILY PRETREATED PATIENTS WITH HODGKIN'S DISEASE: AN ANALYSIS OF PROGNOSTIC FACTORS IN TWO CHEMOTHERAPY TRIALS AND THE LITERATURESTRAUS DJ; PASSE S; KOZINER B et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 207-211; BIBL. 12 REF.Article

Hodgkin's disease, clinical stages I, II A-B and IIIA : results of brief chemotherapy followed by irradiationFERME, C; LEPAGE, E; BOIRON, M et al.Nouvelle revue française d'hématologie. 1992, Vol 34, Num 3, pp 247-255, issn 0029-4810Article

Traitement de la maladie de Hodgkin chez l'enfant par chimiothérapie et irradiation à faible dose = Treatment of childhood Hodgkin's disease with chemotherapy and low dose irradiationLEVERGER, G; OBERLIN, O; SCHAISON, G et al.Nouvelle revue française d'hématologie. 1987, Vol 29, Num 1, pp 83-85, issn 0029-4810Article

  • Page / 3